Half of patients with GBM present with headaches at diagnosis, which is attributed to increases in intracranial pressure (Table 2). 11 Papilledema, now rarely seen because imaging is typically ...

Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel ...

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis. Its ...

(A) Homogenous time-resolved fluorescence (HTRF) assay screening schematic. (B) HTRF assay screening compounds. (C) HTRF assay showed that the effect of FX1, BI-3802, and YK01 blocked the interaction ...

Glioblastoma multiforme cells, illustration. Glioblastoma multiforme is a malignant tumor that arises from astrocytes, one of the support cells of the brain. It is an aggressive cancer with a poor ...

Imagine a cancer so aggressive that even after intensive surgery, radiation, and chemotherapy, nearly 90 percent of patients see it return within two years. This is the terrifying reality of ...

Researchers have secured two key grants to investigate targeting a gene for the first time as a new approach to treat glioblastoma, a very aggressive and fast-growing type of brain cancer. Florida ...